Rosiglitazone protects against endotoxin-induced acute liver injury in rats

National Medical Journal of China

Volumn 95, Issue 39, 2015, Pages 3180-3183

  Bu, Yanan ^a   Yu, Jian ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Acute; Interleukin 12; Liver failure; Rosiglitazone; Sepsis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYTOKINE; DIMETHYL SULFOXIDE; ENDOTOXIN; INTERLEUKIN 12; ROSIGLITAZONE; SODIUM CHLORIDE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; 2,4-THIAZOLIDINEDIONE;

ABDOMEN; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CECAL LIGATION AND PUNCTURE; CECUM; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; DENSITOMETRY; DISSECTION; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; LIGATION; LIVER DISEASE; LIVER INJURY; LIVER PROTECTION; NONHUMAN; PLASMA; PUNCTURE; RAT; SEPSIS; SHAM PROCEDURE; STUDENT T TEST; ANIMAL; LIVER; TOXIC HEPATITIS;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CYTOKINES; DRUG-INDUCED LIVER INJURY; ENDOTOXINS; LIVER; RATS; SEPSIS; THIAZOLIDINEDIONES;

EID: 84948410091     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2015.39.006     Document Type: Article

References (14)

1. Bellinger RP, Levy MM, Andrew R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock:2012 [J] . Inten Care Med, 2013, 39(2) :165-228.
2. Contrael KM, Killian AJ, Gregg SR, et al. Prescribing patterns of hhydrocortisone in septic shock: a single-center experience of how surviving sepsis guidelines are interpreted and translated into bedside practice [J] . Crit Care Med, 2013, 41 (10) :2310-2317.
3. Chung SW, Kang BY, Kim SH, et al. Oxidized low density lipoprotein inhibits inlerleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-y and nuclear factor-KB [J] . J Biol Chem, 2000, 275(42) :32681-32687.
4. Daynes RA, Jones DC. Emerging roles of PPARs in inflammation and immunity [J] . Nat Rev Immunol, 2002, 2(10) :748-759.
5. Jiang C, Ting AT, Seed B. PPAR-y agonists inhibit production of monocyte inflammatory cytokines [J] . Nature, 1998, 391 (6662): 82-86.
6. Ricote M, Li AC, Willson TM, et al. The peroxisome proliferator- activated reeeptor-'Y is a negative regulator of macrophage activation [J] . Nature, 1998, 391 (6662) :79-82.
7. Hubbard WJ, Choudhry M, Sehwacha MG, et al. Cecal ligation and puncture [J] . Shock, 2005, 24:52-57.
8. Wichterman KA, Baue AE, Chaudry IH. Sepsis and septic shock; a review of laboratory models and a proposal [J] . J Surg Res, 1980, 29(2): 189-201.
9. Daynes RA, Jones DC. Emerging roles of PPARs in inflammation and immunity [J] . Nat Rev Immunol, 2002, 2(10) :748-759.
10. Y ang FL, Subeq YM, Lee CJ, et al. Rosiglitazone protects against severe hemorrhagic shock-induced organ damage in rats [J] . Ann Transplant, 2011, 17(10) :BR282-BR289.
11. Haraguchi G, Kosuge H, Maejima Y, et al. Pioglitazone reduces systematic inflammation and improves mortality in apolipoprotein E knockout mice with sepsis [J] . Inten Care Med, 2008, 34 (7): 1304-1312.
12. J Sanchez-Hidalgo M, Martin AR.Villegas I, et al. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats [J] . J Biochem Phamacol, 2005, 69(12):1733-1744.
13. Yin Z, Zhang DH, Welte T, et al. Dominance of IL-12 over IL4 in-yS T cell differentiation leads to default production of IFN-y; failure to down-regulate IL-12 receptor p2-chain expression [J] . J Immunol, 2000, 164 (6) :3056-3064.
14. Gollob JA, Murphy EA, Mahajan S, et al. Altered interleukin-12 responsiveness in Thl and Th2 cells is associated with the differential activation of STAT5 and STAT1 [J] . Blood, 1998, 91 (4): 1341-1354.